GetTopicDetailResponse(id=1b2f1232007b, topicName=博度曲妥珠單抗, introduction=, content=博度曲妥珠單抗, image=null, comments=0, allHits=109, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Jan 10 13:46:52 CST 2025, time=2025-01-10, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=500349, tagList=[TagDto(tagId=500349, tagName=博度曲妥珠單抗)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2247439, encodeId=336e224e43995, content=<a href='/topic/show?id=1b2f1232007b' target=_blank style='color:#2F92EE;'>#博度曲妥珠單抗#</a>, objectTitle=博度曲妥珠單抗申報經治HER2陽性乳腺癌適應癥，腫瘤緩解率73.9%！, objectType=article, longId=859064, objectId=12fc85906452, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393182004_4754896.jpeg, objectUrl=/article/show_article.do?id=12fc85906452, replyNumber=0, likeNumber=25, createdTime=2025-01-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=12fc85906452, moduleTitle=博度曲妥珠單抗申報經治HER2陽性乳腺癌適應癥，腫瘤緩解率73.9%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=12fc85906452)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-10發(fā)表于威斯康星
